Heramed (HMD) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXResignation and Appointment of Joint Company Secretary
other announcement
KalkineHeraMed Director Timothy Chapman’s Unlisted Options Expire Amid Shareholding Update and Equity Restructuring
HeraMed Limited (ASX: HMD) announced a change in director Timothy Chapman’s relevant interests following the expiration of unlisted options on 20 July 2026. Chapman continues to hold 5.28 million fully paid ordinary shares and remains a major shareholder through his stake in Inverness Capital Pty Ltd. This update outlines shifts in Chapman's equity holdings as certain option tranches expired, highlighting potential effects on the company’s capital structure and executive incentive programs. ...
Change of Director's Interest Notice - TC
director_dealing announcement
HeraMED Strengthens Digital Pregnancy Care Through US Pilot Success
Highlights HeraMED completes a successful maternity care pilot with a major US healthcare provider. Pilot showcases stronger virtual pregnancy monitoring and clinical workflow efficiency. Phase expansion discussions are progressing following the pilot's completion. HeraMED has completed an important maternity care pilot that highlights the growing role of digital healthcare and remote pregnancy monitoring. The completed programme has opened the path for further discussions around expandin...
Small CapsHeraMED successfully completes Phase 1 pilot with Lee Health
other announcement
Google NewsShould Investors Keep Watching HeraMED (ASX:HMD) After Its 320% Share Price Gain? - Kalkine
Should Investors Keep Watching HeraMED (ASX:HMD) After Its 320% Share Price Gain? Kalkine
Change of Director's Interest Notice - AG
director_dealing announcement
Notification regarding unquoted securities - HMD
other announcement
Change of Director's Interest Notice TC AG DH SR
director_dealing announcement
Notification regarding unquoted securities - HMD
other announcement
Change of Director's Interest Notice TC DH SR
director_dealing announcement
Notification regarding unquoted securities - HMD
other announcement
Letter to Shareholders, Notice of AGM & Proxy Form
other announcement
Notification regarding unquoted securities - HMD
other announcement
Change of Director's Interest Notice - SR
director_dealing announcement
Change of Director's Interest Notice - AG
director_dealing announcement
Letter to Shareholders, Notice of EGM & Proxy Form
other announcement
Dr Adam Myers- Chair of Commercial Scientific Advisory Board
other announcement
HeraMED completes $3.2 million placement
capital_raise announcement
CHANGE OF AUDITOR & APPOINTMENT OF JOINT COMPANY SECRETARY
other announcement
HeraMED partners with Lee Health- digital maternity solution
other announcement
HeraMED partners with Philips for US maternity solution
other announcement
HeraBEAT receives upgraded TGA regulatory classification
other announcement
Appointment of Non-Executive Director - Dr Sharon R. Howell
other announcement
HeraMED accelerates its next generation AI roadmap
other announcement